Apogee
Stories
-
Paragon Labs expands leadership with former Apogee executives
Paragon Labs announced that former senior leaders from Apogee Therapeutics have joined its team, led by Michael Henderson, M.D., to support clinical development of Paragon-discovered assets. The move follows Apogee's 2026 acquisition by AbbVie for over $10.9 billion.